Letters

Relation of C pneumoniae antibodies to ischaemic heart disease

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7224.1575 (Published 11 December 1999) Cite this as: BMJ 1999;319:1575

Why were samples weakly positive for IgG antibodies not tested for IgA antibodies?

  1. David Taylor-Robinson, emeritus professor of genitourinary microbiology and medicine,
  2. Brenda J Thomas, research fellow
  1. Department of Genitourinary Medicine and Communicable Diseases, Imperial College School of Medicine, St Mary's Hospital, London W2 1NY
  2. Finnish Lung Health Association, Sibeliuksenkatu 11 A 1, 00250 Helsinki, Finland
  3. Department of Public Health and General Practice, University of Turku, Lemminkäisenkatu 1, 20520 Turku, Finland
  4. Unit of General Practice, Oulu University Hospital, Aapistie 1, 90220 Oulu, Finland
  5. National Public Health Institute, PO Box 310, 90101 Oulu

    EDITOR—The relation of Chlamydia pneumoniae antibodies to ischaemic heart disease reported by Strachan et al, and the commentary on the paper, deserve comment.1 An association is reported between IgA antibody at the start of the study and prevalent ischaemic heart disease or subsequent death due to ischaemic heart disease. Presumably, serum samples with an IgG antibody titre of <1 in 16 were not tested for IgA antibody because it was thought that IgA antibody would not exist. Why, however, were 310 samples that were weakly positive for IgG antibodies not tested for IgA antibodies? Surely some of these could have been weakly positive for IgA antibodies at 1 in 16 and so have influenced the interpretation of results?

    Persistent IgA antibody is thought to indicate a chronic infection, as is persistent IgG antibody. Conceptually, therefore, it is difficult to understand why significance should apply apparently only to the presence of IgA antibodies, particularly as others have shown an association with IgG antibodies. Furthermore, as West mentions, there is a problem of relating events to antibody measured only once.1 Obviously, IgA antibodies may persist but also disappear. We wonder what …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe